P21WAF1/CIP1 protein and tongue cancer prognosis

Anticancer Research

Volumn 24, Issue 5 B, 2004, Pages 3225-3231

  Gonzalez Moles, Miguel Angel ^a,e   Ruiz Avila, I ^b   Fernandez Martinez J A ^a   Gil Montoya, J A ^a   Esteban, F ^c   Gonzalez Moles, S ^a   Bravo Perez, M ^f   Bascones, A ^d  

^a UNIVERSITY OF GRANADA   (Spain)

^b Hospital of Jaen   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^e School of Dentistry   (Spain)

^f NONE

Author keywords

p21waf1 cip1; Prognosis; Tongue cancer

Indexed keywords

CELL CYCLE PROTEIN; PROTEIN P21; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CELL HYPERPLASIA; CELL SURVIVAL; DYSPLASIA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TONGUE CANCER; TUMOR CELL; BIOSYNTHESIS; CANCER STAGING; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TONGUE TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL RATE; TONGUE NEOPLASMS;

EID: 6344221652     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Silverberg E: Cancer statistics. CA Cancer J Clin 36: 9-25, 1986.
2. Hoffman HT, Karnell LH, Funk GF, Robinson RA and Menck HR: The (1998) National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg 124: 951-62, 1998.
3. El-Husseiny G, Kandil A, Jamshed A, Khafaga Y, Saleem M, Allam A, Al-Rajhi N, Al-Amro A, Rostom AY, Abuzeid M, Otieschan A and Flores AD: Squamous cell carcinoma of the oral tongue: an analysis of prognostic factors. Br J Oral Maxillofac Surg 38: 193-9, 2000.
4. Prince S and Bailey BM: Squamous carcinoma of the tongue: review. Br J Oral Maxillofac Surg 37: 164-74, 1999.
5. Krause CJ, Lee JG and McCabe BF: Carcinoma of the oral cavity. Arch Otolaryngol 97: 354-8, 1973.
6. Lee JG and Litton WB: Occult regional metastasis: carcinoma of the oral tongue. Laryngoscope 82: 1273-81, 1972.
7. Hibbert J, Marks NJ, Winter PJ and Shaheen OH: Prognostic factors in oral squamous carcinoma and their relation to clinical staging. Clin Otolaryngol 8: 197-203, 1983.
8. Moore C, Flynn MB and Greenberg RA: Evaluation of size in prognosis of oral cancer. Cancer 58: 158-62, 1986.
9. Arcangeli G, Mauro F, Nervi C and Starace G: A critical appraisal of the usefulness of some biological parameters in predicting tumour radiation response of human head and neck cancer. Br J Cancer (Suppl) 41: 39-44, 1980.
10. Tralongo V, Rodolico V, Luciani A, Marra G and Daniele E: Prognostic factors in oral squamous cell carcinoma. A review of the literature. Anticancer Res 19: 3503-10, 1999.
11. Gonzalez-Moles MA, Esteban F, Rodriguez-Archilla A, Ruiz-Avila I and Gonzalez-Moles S: Importance of tumour thickness measurement in prognosis of tongue cancer. Oral Oncol 38: 394-7, 2002.
12. Gonzalez-Moles MA, Galindo P, Gutierrez J, Rodriguez-Archilla A, Ruiz-Avila I and Sanchez-Fernandez E: Significance of p53 expression in non-tumoral epithelium adjacent to oral squamous cell carcinomas. J Laryngol Otol 116: 355-8, 2002.
13. waf1/ciP1 is a universal inhibitor of cyclin kinases. Nature 366: 701-4, 1993.
14. waf1/ciP1 expression in the surgical management of lingual squamous cell carcinoma. Am J Clin Pathol 116: 240-5, 2001.
15. Flores-Rozas H, Kelman Z, Dean FB, Pan ZQ, Harper JW, Elledge SJ, O'Donnell M and Hurwitz J: Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. Proc Natl Acad Sci USA 91: 8655-9, 1994.
16. waf1/cip1 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371: 534-7, 1994.
17. Skapek SX, Rhee J, Spicer DB and Lassar AB: Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267: 1022-4, 1995.
18. waf1/cip1 cyclin-dependent kinase inhibitor suppresses turnorigenicity in vivo. Nat Med 1: 1052-6, 1995.
19. waf1/cip1, WAF1/CIP1, expression in the absence of p53. Oncogene 9: 3397-406, 1994.
20. Noda A, Ning Y, Venable SF, Pereira-Smith OM and Smith JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211: 90-8, 1994.
21. waf1/cip1/waf1/cip1and mdm-2 expression in breast carcinoma patients as related to prognosis. Int J Cancer 74: 529-34, 1997.
22. waf1/cip1 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung. Clin Cancer Res 3: 1831-5, 1997.
23. waf1/cip1/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer. Br J Cancer 79: 1870-8, 1999.
24. waf1/cip1(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up. Clin Cancer Res 2: 1591-9, 1996.
25. Zlotta AR, Noel JC, Fayt I, Drowart A, Van Vooren JP, Huygen K, Simon J and Schulman CC: Correlation and prognostic significance of p53, p21waf1/cip1WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy. J Urol 161: 792-8, 1999.
26. Xie X, Clausen OP and Boysen M: Prognostic significance of p21waf1/cip1WAF1/CIP1 expression in tongue squamous cell carcinomas. Arch Otolaryngol Head Neck Surg 128: 897-902, 2002.
27. Regezi JA, Dekker NP, McMillan A, Ramirez-Amador V, Meneses-Garcia A, Ruiz-Godoy Rivera LM, Chrysomali E and Ng 10: p53, p21waf1/cip1, Rb, and MDM2 proteins in tongue carcinoma from patients < 35 versus > 75 years. Oral Oncol 35: 379-83, 1999.
28. Myers JN, Elkins T, Roberts D and Byers RM: Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg 122: 44-51, 2000.
29. Spiessl B: International Union Against Cancer. TNM Atlas Illustrated Guide to the TNM/pTNM Classification of Malignant Tumors. 3rd ed., 2nd revision edition. Berlin, New York: Springer-Verlag, 1992.
30. Chang KW, Lin SC, Kwan PC and Wong YK: Association of aberrant p53 and p21waf1/cip1(WAF1) immunoreactivity with the outcome of oral verrucous leukoplakia in Taiwan. J Oral Pathol Med 29: 56-62, 2000.
31. Schoelch ML, Regezi JA, Dekker NP, Ng IO, McMillan A, Ziober BL, Le QT, Silverman S and Fu KK: Cell cycle proteins and the development of oral squamous cell carcinoma. Oral Oncol 35: 333-42, 1999.
32. Noda A, Ning Y, Venable SF, Pereira-Smith OM and Smith JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211: 90-8, 1994.
33. Poluha W, Poluha DK, Chang B, Crosbie NE, Schonhoff CM, Kilpatrick DL and Ross AH: The cyclin-dependent kinase inhibitor p21waf1/cip1 (WAF1) is required for survival of differentiating neuroblastoma cells. Mol Cell Biol 16: 1335-41, 1996.
34. Wang and Walsh K: Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273: 359-61, 1996.
35. Sheikh MS, Li XS, Chen JC, Shao ZM, Ordonez JV and Fontana JA: Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 9: 3407-15, 1994.
36. Frank JL Bur ME, Garb JL, Kay S, Ware JL, Sismanis A and Neifeld JP: p53 tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx. Cancer 73: 181-6, 1994.
37. Ogden GR, Kiddie RA, Lunny DP and Lane DP: Assessment of p53 protein expression in normal, benign, and malignant oral mucosa. J Pathol 166: 389-94, 1992.
38. Agarwal S, Mathur M, Shukla NK and Ralhan R: Expression of cyclin dependent kinase inhibitor p21waf1/cip1waf1/cip1 in premalignant and malignant oral lesions: relationship with p53 status. Oral Oncol 34: 353-60, 1998.
39. Kudo Y, Takata T, Ogawa I, Sato S and Nikai H: Expression of p53 and p21waf1/cip1CIP1/WAF1 proteins in oral epithelial dysplasias and squamous cell carcinomas. Oncol Rep 6: 539-45, 1999.
40. Warnakulasuriya KA and Johnson NW: Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions. J Oral Pathol Med 21: 404-8, 1992.
41. Shin DM, Kim J, Ro JY, Hittelman J, Roth JA, Hong WK and Hittelman WN: Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 54: 321-6, 1994.
42. Lavieille JP, Brambilla E, Riva-Lavieille C, Reyt E, Charachon R and Brambilla C: Immunohistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck. Acta Otolaryngol 115: 334-9, 1995.
43. Regezi JA, Zarbo RJ, Regev E, Pisanty S, Silverman S and Gazit D: p53 protein expression in sequential biopsies of oral dysplasias and in situ carcinomas. J Oral Pathol Med 24: 18-22, 1995.
44. Gonzalez-Moles MA, Galindo P, Gutierrez-Fernandez J, Sanchez-Fernandez E, Rodriguez-Archilla A, Ruiz-Avila I and Bravo M: P53 protein expression in oral squamous cell carcinoma: Survival analysis. Anticancer Res 21: 2889-94, 2001.
45. Pande P, Soni S, Kaur J, Agarwal S, Mathur M, Shukla NK and Ralhan R: Prognostic factors in betel and tobacco related oral cancer. Oral Oncol 38: 491-9, 2000.
46. Yook JI and Kim J: Expression of p21waf1/cip1WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas. Oral Oncol 34: 198-203, 1998.
47. Kuo MY, Chang HH, Hahn LJ, Wang JT and Chiang CP: Elevated ras p21waf1/cip1 expression in oral premalignant lesions and squamous cell carcinoma in Taiwan. J Oral Pathol Med 24: 255-60, 1995.
48. Spandidos DA, Lamothe A and Field JK: Multiple transcriptional activation of cellular oncogenes in human head and neck solid tumours. Anticancer Res 5: 221-4, 1985.
49. Tatemoto Y, Osaki T, Yoneda K, Yamamoto T, Ueta E and Kimura T: Expression of p53 and p21waf1/cip1 proteins in oral squamous cell carcinoma: correlation with lymph node metastasis and response to chemoradiotherapy. Pathol Res Pract 194: 821-30, 1998.
50. Kapranos N, Stathopoulos GP, Manolopoulos L, Kokka E, Papadimitriou C, Bibas A, Yiotakis J and Adamopoulos G: p53, p21waf1/cip1 and p27 protein expression in head and neck cancer and their prognostic value. Anticancer Res 21: 521-8, 2001.
51. Tsuji T, Sasaki K and Shinozaki F: An expression of squamous cell carcinoma-related antigen in oral cancers. Int J Oral Maxillofac Surg 18: 241-3, 1989.